PMC Articles for MedGen (Select 1788246) - PMC

Select item 84378731.

Volumetric study reveals the relationship between outcome and early radiographic response during bevacizumab-containing chemoradiotherapy for unresectable glioblastoma

Kosuke Takigawa, Nobuhiro Hata, Yuhei Michiwaki, Akio Hiwatashi, Hajime Yonezawa, Daisuke Kuga, Ryusuke Hatae, Yuhei Sangatsuda, Yutaka Fujioka, Yusuke Funakoshi, Ryosuke Otsuji, Aki Sako, Osamu Togao, Takashi Yoshiura, Koji Yoshimoto, Masahiro Mizoguchi

J Neurooncol. 2021; 154(2): 187–196. Published online 2021 Jul 28. doi: 10.1007/s11060-021-03812-9

PMCID:: PMC8437873

Abstract Article PDF–1.0M

Select item 48933522.

Prognostic value of health‐related quality of life for death risk stratification in patients with unresectable glioblastoma

Brice Paquette, Dewi Vernerey, Bruno Chauffert, Sandrine Dabakuyo, Loic Feuvret, Luc Taillandier, Didier Frappaz, Hervé Taillia, Roland Schott, François Ducray, Michel Fabbro, Isabelle Tennevet, François Ghiringhelli, Jean‐Sébastien Guillamo, Xavier Durando, Daniel Castera, Marc Frenay, Chantal Campello, Cécile Dalban, Jérome Skrzypski, Olivier Chinot, Amélie Anota, Franck Bonnetain

Cancer Med. 2016 Aug; 5(8): 1753–1764. Published online 2016 Jun 1. doi: 10.1002/cam4.734

PMCID:: PMC4893352

Abstract Article PDF–139K

Select item 44922393.

Phase II Trial of Upfront Bevacizumab, Irinotecan, and Temozolomide for Unresectable Glioblastoma

Katherine B. Peters, Emil Lou, Annick Desjardins, David A. Reardon, Eric S. Lipp, Elizabeth Miller, James E. Herndon, II, Frances McSherry, Henry S. Friedman, James J. Vredenburgh

Oncologist. 2015 Jul; 20(7): 727–728. Published online 2015 May 29. doi: 10.1634/theoncologist.2015-0135

PMCID:: PMC4492239

Abstract Article PDF–543K

Select item 91453624.

Combination of DNA Vaccine and Immune Checkpoint Blockades Improves the Immune Response in an Orthotopic Unresectable Glioblastoma Model

Mathilde Bausart, Kevin Vanvarenberg, Bernard Ucakar, Alessandra Lopes, Gaëlle Vandermeulen, Alessio Malfanti, Véronique Préat

Pharmaceutics. 2022 May; 14(5): 1025. Published online 2022 May 10. doi: 10.3390/pharmaceutics14051025

PMCID:: PMC9145362

Abstract Article PDF–1.6M

Select item 65943775.

Phenotypic Plasticity of Invasive Edge Glioma Stem-like Cells in Response to Ionizing Radiation

Mutsuko Minata, Alessandra Audia, Junfeng Shi, Songjian Lu, Joshua Bernstock, Marat S. Pavlyukov, Arvid Das, Sung-Hak Kim, Yong Jae Shin, Yeri Lee, Harim Koo, Kirti Snigdha, Indrayani Waghmare, Xing Guo, Ahmed Mohyeldin, Daniel Gallego-Perez, Jia Wang, Dongquan Chen, Peng Cheng, Farah Mukheef, Minerva Contreras, Joel F. Reyes, Brian Vaillant, Erik P. Sulman, Shi-Yuan Cheng, James M. Markert, Bakhos A. Tannous, Xinghua Lu, Madhuri Kango-Singh, L. James Lee, Do-Hyun Nam, Ichiro Nakano, Krishna P. Bhat

Cell Rep. Author manuscript; available in PMC 2019 Jun 26.

Published in final edited form as: Cell Rep. 2019 Feb 12; 26(7): 1893–1905.e7. doi: 10.1016/j.celrep.2019.01.076

PMCID:: PMC6594377

Abstract Article PDF–1.2M

Select item 36396576.

Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma

Emil Lou, Katherine B Peters, Ashley L Sumrall, Annick Desjardins, David A Reardon, Eric S Lipp, James E Herndon, II, April Coan, Leighann Bailey, Scott Turner, Henry S Friedman, James J Vredenburgh

Cancer Med. 2013 Apr; 2(2): 185–195. Published online 2013 Jan 24. doi: 10.1002/cam4.58

PMCID:: PMC3639657

Abstract Article PDF–487K

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from MedGen

Items: 6

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity